11-hydroxyyohimbine has been researched along with Hypertension in 1 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flockhart, DA; Ho, H; Insel, PA; Kailasam, MT; Kennedy, BP; Le Corre, P; Leverge, R; O'connor, DT; Parmer, RJ; Schork, NJ; Skaar, TP; Smith, DW; Ziegler, MG | 1 |
1 other study(ies) available for 11-hydroxyyohimbine and Hypertension
| Article | Year |
|---|---|
Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analysis of Variance; Biological Availability; Blood Pressure; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Ethnicity; Female; Genotype; Humans; Hypertension; Infusions, Intravenous; Male; Metabolic Clearance Rate; Polymorphism, Genetic; Receptors, Adrenergic, alpha-2; Sensitivity and Specificity; Vascular Resistance; Yohimbine | 2004 |